nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—AHR—Atorvastatin—coronary artery disease	0.22	0.365	CbGbCtD
Leflunomide—ABCG2—Pitavastatin—coronary artery disease	0.0407	0.0677	CbGbCtD
Leflunomide—ABCG2—Telmisartan—coronary artery disease	0.0407	0.0677	CbGbCtD
Leflunomide—ABCG2—Rosuvastatin—coronary artery disease	0.03	0.0499	CbGbCtD
Leflunomide—ABCG2—Ezetimibe—coronary artery disease	0.03	0.0499	CbGbCtD
Leflunomide—ABCG2—Pravastatin—coronary artery disease	0.0273	0.0454	CbGbCtD
Leflunomide—CYP2C9—Fenofibrate—coronary artery disease	0.025	0.0415	CbGbCtD
Leflunomide—CYP1A2—Gemfibrozil—coronary artery disease	0.0222	0.0368	CbGbCtD
Leflunomide—CYP2C9—Gemfibrozil—coronary artery disease	0.02	0.0332	CbGbCtD
Leflunomide—CYP1A2—Clopidogrel—coronary artery disease	0.0192	0.0319	CbGbCtD
Leflunomide—CYP2C9—Clopidogrel—coronary artery disease	0.0173	0.0288	CbGbCtD
Leflunomide—CYP2C9—Pitavastatin—coronary artery disease	0.0151	0.0252	CbGbCtD
Leflunomide—CYP2C9—Valsartan—coronary artery disease	0.0147	0.0245	CbGbCtD
Leflunomide—CYP2C9—Rosuvastatin—coronary artery disease	0.0112	0.0185	CbGbCtD
Leflunomide—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.0109	0.0181	CbGbCtD
Leflunomide—CYP2C9—Simvastatin—coronary artery disease	0.0104	0.0172	CbGbCtD
Leflunomide—CYP2C9—Lovastatin—coronary artery disease	0.0102	0.0169	CbGbCtD
Leflunomide—CYP2C9—Pravastatin—coronary artery disease	0.0102	0.0169	CbGbCtD
Leflunomide—CYP1A2—Losartan—coronary artery disease	0.00939	0.0156	CbGbCtD
Leflunomide—CYP2C9—Atorvastatin—coronary artery disease	0.00925	0.0154	CbGbCtD
Leflunomide—CYP2C9—cardial valve—coronary artery disease	0.00868	0.29	CbGeAlD
Leflunomide—CYP2C9—Losartan—coronary artery disease	0.00846	0.0141	CbGbCtD
Leflunomide—Niflumic Acid—PLA2G1B—coronary artery disease	0.00345	0.886	CrCbGaD
Leflunomide—DHODH—heart—coronary artery disease	0.0026	0.0867	CbGeAlD
Leflunomide—DHODH—cardiac atrium—coronary artery disease	0.00222	0.0742	CbGeAlD
Leflunomide—DHODH—Lovastatin—Simvastatin—coronary artery disease	0.00215	0.5	CbGdCrCtD
Leflunomide—DHODH—Lovastatin—Pravastatin—coronary artery disease	0.00215	0.5	CbGdCrCtD
Leflunomide—AHR—cardiac ventricle—coronary artery disease	0.00206	0.0688	CbGeAlD
Leflunomide—DHODH—blood—coronary artery disease	0.00194	0.0647	CbGeAlD
Leflunomide—AHR—myocardium—coronary artery disease	0.00194	0.0647	CbGeAlD
Leflunomide—PTK2B—heart—coronary artery disease	0.00165	0.0549	CbGeAlD
Leflunomide—PTK2B—cardiovascular system—coronary artery disease	0.00155	0.0518	CbGeAlD
Leflunomide—AHR—heart—coronary artery disease	0.00135	0.0452	CbGeAlD
Leflunomide—PTK2B—blood—coronary artery disease	0.00123	0.041	CbGeAlD
Leflunomide—AHR—cardiac atrium—coronary artery disease	0.00116	0.0386	CbGeAlD
Leflunomide—AHR—blood—coronary artery disease	0.00101	0.0337	CbGeAlD
Leflunomide—ABCG2—heart—coronary artery disease	0.000525	0.0175	CbGeAlD
Leflunomide—CYP2C9—heart—coronary artery disease	0.00048	0.016	CbGeAlD
Leflunomide—CYP2C9—cardiovascular system—coronary artery disease	0.000453	0.0151	CbGeAlD
Leflunomide—Niflumic Acid—PTGS2—coronary artery disease	0.000442	0.114	CrCbGaD
Leflunomide—ABCG2—blood—coronary artery disease	0.000392	0.0131	CbGeAlD
Leflunomide—CYP1A2—blood—coronary artery disease	0.000377	0.0126	CbGeAlD
Leflunomide—CYP2C9—blood—coronary artery disease	0.000358	0.0119	CbGeAlD
Leflunomide—Angioedema—Lisinopril—coronary artery disease	5.24e-05	0.00022	CcSEcCtD
Leflunomide—Pruritus—Olmesartan—coronary artery disease	5.24e-05	0.00022	CcSEcCtD
Leflunomide—Decreased appetite—Losartan—coronary artery disease	5.24e-05	0.00022	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	5.23e-05	0.000219	CcSEcCtD
Leflunomide—Abdominal pain—Captopril—coronary artery disease	5.23e-05	0.000219	CcSEcCtD
Leflunomide—Body temperature increased—Captopril—coronary artery disease	5.23e-05	0.000219	CcSEcCtD
Leflunomide—Dizziness—Simvastatin—coronary artery disease	5.21e-05	0.000219	CcSEcCtD
Leflunomide—Rash—Ezetimibe—coronary artery disease	5.21e-05	0.000219	CcSEcCtD
Leflunomide—Dermatitis—Ezetimibe—coronary artery disease	5.21e-05	0.000219	CcSEcCtD
Leflunomide—Discomfort—Timolol—coronary artery disease	5.2e-05	0.000218	CcSEcCtD
Leflunomide—Asthenia—Niacin—coronary artery disease	5.19e-05	0.000218	CcSEcCtD
Leflunomide—Fatigue—Losartan—coronary artery disease	5.19e-05	0.000218	CcSEcCtD
Leflunomide—Headache—Ezetimibe—coronary artery disease	5.18e-05	0.000217	CcSEcCtD
Leflunomide—Malaise—Lisinopril—coronary artery disease	5.17e-05	0.000217	CcSEcCtD
Leflunomide—Anaphylactic shock—Ramipril—coronary artery disease	5.16e-05	0.000217	CcSEcCtD
Leflunomide—Vertigo—Lisinopril—coronary artery disease	5.16e-05	0.000216	CcSEcCtD
Leflunomide—Dry mouth—Timolol—coronary artery disease	5.15e-05	0.000216	CcSEcCtD
Leflunomide—Pain—Losartan—coronary artery disease	5.15e-05	0.000216	CcSEcCtD
Leflunomide—Constipation—Losartan—coronary artery disease	5.15e-05	0.000216	CcSEcCtD
Leflunomide—Vomiting—Eplerenone—coronary artery disease	5.15e-05	0.000216	CcSEcCtD
Leflunomide—Feeling abnormal—Furosemide—coronary artery disease	5.14e-05	0.000216	CcSEcCtD
Leflunomide—Leukopenia—Lisinopril—coronary artery disease	5.14e-05	0.000215	CcSEcCtD
Leflunomide—Nausea—Fenofibrate—coronary artery disease	5.13e-05	0.000215	CcSEcCtD
Leflunomide—Pruritus—Niacin—coronary artery disease	5.12e-05	0.000215	CcSEcCtD
Leflunomide—Asthenia—Pravastatin—coronary artery disease	5.11e-05	0.000215	CcSEcCtD
Leflunomide—Gastrointestinal pain—Furosemide—coronary artery disease	5.1e-05	0.000214	CcSEcCtD
Leflunomide—Rash—Eplerenone—coronary artery disease	5.1e-05	0.000214	CcSEcCtD
Leflunomide—Urticaria—Perindopril—coronary artery disease	5.1e-05	0.000214	CcSEcCtD
Leflunomide—Hypersensitivity—Trandolapril—coronary artery disease	5.1e-05	0.000214	CcSEcCtD
Leflunomide—Dermatitis—Eplerenone—coronary artery disease	5.1e-05	0.000214	CcSEcCtD
Leflunomide—Diarrhoea—Valsartan—coronary artery disease	5.1e-05	0.000214	CcSEcCtD
Leflunomide—Hypersensitivity—Enalapril—coronary artery disease	5.08e-05	0.000213	CcSEcCtD
Leflunomide—Abdominal pain—Perindopril—coronary artery disease	5.08e-05	0.000213	CcSEcCtD
Leflunomide—Body temperature increased—Perindopril—coronary artery disease	5.08e-05	0.000213	CcSEcCtD
Leflunomide—Palpitations—Lisinopril—coronary artery disease	5.07e-05	0.000213	CcSEcCtD
Leflunomide—Diarrhoea—Olmesartan—coronary artery disease	5.07e-05	0.000213	CcSEcCtD
Leflunomide—Headache—Eplerenone—coronary artery disease	5.07e-05	0.000213	CcSEcCtD
Leflunomide—Nervous system disorder—Ramipril—coronary artery disease	5.06e-05	0.000212	CcSEcCtD
Leflunomide—Thrombocytopenia—Ramipril—coronary artery disease	5.06e-05	0.000212	CcSEcCtD
Leflunomide—Anaphylactic shock—Timolol—coronary artery disease	5.05e-05	0.000212	CcSEcCtD
Leflunomide—Pruritus—Pravastatin—coronary artery disease	5.04e-05	0.000212	CcSEcCtD
Leflunomide—Nausea—Clopidogrel—coronary artery disease	5.04e-05	0.000211	CcSEcCtD
Leflunomide—Tachycardia—Ramipril—coronary artery disease	5.04e-05	0.000211	CcSEcCtD
Leflunomide—Skin disorder—Ramipril—coronary artery disease	5.02e-05	0.00021	CcSEcCtD
Leflunomide—Infection—Timolol—coronary artery disease	5.02e-05	0.00021	CcSEcCtD
Leflunomide—Vomiting—Simvastatin—coronary artery disease	5.01e-05	0.00021	CcSEcCtD
Leflunomide—Hypersensitivity—Telmisartan—coronary artery disease	5.01e-05	0.00021	CcSEcCtD
Leflunomide—Cough—Lisinopril—coronary artery disease	5.01e-05	0.00021	CcSEcCtD
Leflunomide—Nausea—Lovastatin—coronary artery disease	5.01e-05	0.00021	CcSEcCtD
Leflunomide—Hyperhidrosis—Ramipril—coronary artery disease	4.99e-05	0.000209	CcSEcCtD
Leflunomide—Rash—Simvastatin—coronary artery disease	4.97e-05	0.000209	CcSEcCtD
Leflunomide—Dermatitis—Simvastatin—coronary artery disease	4.97e-05	0.000208	CcSEcCtD
Leflunomide—Asthenia—Trandolapril—coronary artery disease	4.97e-05	0.000208	CcSEcCtD
Leflunomide—Feeling abnormal—Losartan—coronary artery disease	4.96e-05	0.000208	CcSEcCtD
Leflunomide—Urticaria—Furosemide—coronary artery disease	4.96e-05	0.000208	CcSEcCtD
Leflunomide—Diarrhoea—Niacin—coronary artery disease	4.95e-05	0.000208	CcSEcCtD
Leflunomide—Nervous system disorder—Timolol—coronary artery disease	4.95e-05	0.000208	CcSEcCtD
Leflunomide—Asthenia—Enalapril—coronary artery disease	4.95e-05	0.000208	CcSEcCtD
Leflunomide—Headache—Simvastatin—coronary artery disease	4.94e-05	0.000207	CcSEcCtD
Leflunomide—Body temperature increased—Furosemide—coronary artery disease	4.93e-05	0.000207	CcSEcCtD
Leflunomide—Abdominal pain—Furosemide—coronary artery disease	4.93e-05	0.000207	CcSEcCtD
Leflunomide—Gastrointestinal pain—Losartan—coronary artery disease	4.92e-05	0.000207	CcSEcCtD
Leflunomide—Dizziness—Valsartan—coronary artery disease	4.92e-05	0.000207	CcSEcCtD
Leflunomide—Anorexia—Ramipril—coronary artery disease	4.92e-05	0.000207	CcSEcCtD
Leflunomide—Nausea—Ezetimibe—coronary artery disease	4.91e-05	0.000206	CcSEcCtD
Leflunomide—Skin disorder—Timolol—coronary artery disease	4.9e-05	0.000206	CcSEcCtD
Leflunomide—Dizziness—Olmesartan—coronary artery disease	4.9e-05	0.000206	CcSEcCtD
Leflunomide—Pruritus—Trandolapril—coronary artery disease	4.9e-05	0.000205	CcSEcCtD
Leflunomide—Myalgia—Lisinopril—coronary artery disease	4.89e-05	0.000205	CcSEcCtD
Leflunomide—Chest pain—Lisinopril—coronary artery disease	4.89e-05	0.000205	CcSEcCtD
Leflunomide—Arthralgia—Lisinopril—coronary artery disease	4.89e-05	0.000205	CcSEcCtD
Leflunomide—Hyperhidrosis—Timolol—coronary artery disease	4.88e-05	0.000205	CcSEcCtD
Leflunomide—Asthenia—Telmisartan—coronary artery disease	4.88e-05	0.000205	CcSEcCtD
Leflunomide—Pruritus—Enalapril—coronary artery disease	4.88e-05	0.000205	CcSEcCtD
Leflunomide—Diarrhoea—Pravastatin—coronary artery disease	4.88e-05	0.000205	CcSEcCtD
Leflunomide—Anxiety—Lisinopril—coronary artery disease	4.87e-05	0.000204	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	4.85e-05	0.000204	CcSEcCtD
Leflunomide—Discomfort—Lisinopril—coronary artery disease	4.83e-05	0.000202	CcSEcCtD
Leflunomide—Hypotension—Ramipril—coronary artery disease	4.83e-05	0.000202	CcSEcCtD
Leflunomide—Anorexia—Timolol—coronary artery disease	4.81e-05	0.000202	CcSEcCtD
Leflunomide—Pruritus—Telmisartan—coronary artery disease	4.81e-05	0.000202	CcSEcCtD
Leflunomide—Nausea—Eplerenone—coronary artery disease	4.81e-05	0.000202	CcSEcCtD
Leflunomide—Dizziness—Niacin—coronary artery disease	4.79e-05	0.000201	CcSEcCtD
Leflunomide—Urticaria—Losartan—coronary artery disease	4.78e-05	0.000201	CcSEcCtD
Leflunomide—Dry mouth—Lisinopril—coronary artery disease	4.78e-05	0.0002	CcSEcCtD
Leflunomide—Abdominal pain—Losartan—coronary artery disease	4.76e-05	0.0002	CcSEcCtD
Leflunomide—Body temperature increased—Losartan—coronary artery disease	4.76e-05	0.0002	CcSEcCtD
Leflunomide—Asthenia—Captopril—coronary artery disease	4.74e-05	0.000199	CcSEcCtD
Leflunomide—Diarrhoea—Trandolapril—coronary artery disease	4.74e-05	0.000199	CcSEcCtD
Leflunomide—Vomiting—Valsartan—coronary artery disease	4.73e-05	0.000199	CcSEcCtD
Leflunomide—Diarrhoea—Enalapril—coronary artery disease	4.72e-05	0.000198	CcSEcCtD
Leflunomide—Hypotension—Timolol—coronary artery disease	4.72e-05	0.000198	CcSEcCtD
Leflunomide—Dizziness—Pravastatin—coronary artery disease	4.71e-05	0.000198	CcSEcCtD
Leflunomide—Vomiting—Olmesartan—coronary artery disease	4.71e-05	0.000198	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Ramipril—coronary artery disease	4.7e-05	0.000197	CcSEcCtD
Leflunomide—Rash—Valsartan—coronary artery disease	4.7e-05	0.000197	CcSEcCtD
Leflunomide—Dermatitis—Valsartan—coronary artery disease	4.69e-05	0.000197	CcSEcCtD
Leflunomide—Nausea—Simvastatin—coronary artery disease	4.68e-05	0.000196	CcSEcCtD
Leflunomide—Anaphylactic shock—Lisinopril—coronary artery disease	4.68e-05	0.000196	CcSEcCtD
Leflunomide—Pruritus—Captopril—coronary artery disease	4.68e-05	0.000196	CcSEcCtD
Leflunomide—Rash—Olmesartan—coronary artery disease	4.67e-05	0.000196	CcSEcCtD
Leflunomide—Insomnia—Ramipril—coronary artery disease	4.67e-05	0.000196	CcSEcCtD
Leflunomide—Dermatitis—Olmesartan—coronary artery disease	4.67e-05	0.000196	CcSEcCtD
Leflunomide—Headache—Valsartan—coronary artery disease	4.67e-05	0.000196	CcSEcCtD
Leflunomide—Diarrhoea—Telmisartan—coronary artery disease	4.65e-05	0.000195	CcSEcCtD
Leflunomide—Infection—Lisinopril—coronary artery disease	4.65e-05	0.000195	CcSEcCtD
Leflunomide—Headache—Olmesartan—coronary artery disease	4.64e-05	0.000195	CcSEcCtD
Leflunomide—Paraesthesia—Ramipril—coronary artery disease	4.64e-05	0.000195	CcSEcCtD
Leflunomide—Asthenia—Perindopril—coronary artery disease	4.61e-05	0.000193	CcSEcCtD
Leflunomide—Dyspnoea—Ramipril—coronary artery disease	4.6e-05	0.000193	CcSEcCtD
Leflunomide—Vomiting—Niacin—coronary artery disease	4.6e-05	0.000193	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Timolol—coronary artery disease	4.6e-05	0.000193	CcSEcCtD
Leflunomide—Hypersensitivity—Furosemide—coronary artery disease	4.6e-05	0.000193	CcSEcCtD
Leflunomide—Thrombocytopenia—Lisinopril—coronary artery disease	4.59e-05	0.000192	CcSEcCtD
Leflunomide—Dizziness—Trandolapril—coronary artery disease	4.58e-05	0.000192	CcSEcCtD
Leflunomide—Tachycardia—Lisinopril—coronary artery disease	4.57e-05	0.000192	CcSEcCtD
Leflunomide—Insomnia—Timolol—coronary artery disease	4.57e-05	0.000192	CcSEcCtD
Leflunomide—Rash—Niacin—coronary artery disease	4.57e-05	0.000192	CcSEcCtD
Leflunomide—Dermatitis—Niacin—coronary artery disease	4.56e-05	0.000191	CcSEcCtD
Leflunomide—Dizziness—Enalapril—coronary artery disease	4.56e-05	0.000191	CcSEcCtD
Leflunomide—Skin disorder—Lisinopril—coronary artery disease	4.55e-05	0.000191	CcSEcCtD
Leflunomide—Dyspepsia—Ramipril—coronary artery disease	4.55e-05	0.000191	CcSEcCtD
Leflunomide—Pruritus—Perindopril—coronary artery disease	4.54e-05	0.000191	CcSEcCtD
Leflunomide—Headache—Niacin—coronary artery disease	4.54e-05	0.00019	CcSEcCtD
Leflunomide—Paraesthesia—Timolol—coronary artery disease	4.53e-05	0.00019	CcSEcCtD
Leflunomide—Vomiting—Pravastatin—coronary artery disease	4.53e-05	0.00019	CcSEcCtD
Leflunomide—Hyperhidrosis—Lisinopril—coronary artery disease	4.53e-05	0.00019	CcSEcCtD
Leflunomide—Diarrhoea—Captopril—coronary artery disease	4.52e-05	0.00019	CcSEcCtD
Leflunomide—Dyspnoea—Timolol—coronary artery disease	4.5e-05	0.000189	CcSEcCtD
Leflunomide—Dizziness—Telmisartan—coronary artery disease	4.5e-05	0.000189	CcSEcCtD
Leflunomide—Rash—Pravastatin—coronary artery disease	4.5e-05	0.000189	CcSEcCtD
Leflunomide—Dermatitis—Pravastatin—coronary artery disease	4.49e-05	0.000188	CcSEcCtD
Leflunomide—Decreased appetite—Ramipril—coronary artery disease	4.49e-05	0.000188	CcSEcCtD
Leflunomide—Asthenia—Furosemide—coronary artery disease	4.48e-05	0.000188	CcSEcCtD
Leflunomide—Headache—Pravastatin—coronary artery disease	4.47e-05	0.000187	CcSEcCtD
Leflunomide—Anorexia—Lisinopril—coronary artery disease	4.46e-05	0.000187	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Ramipril—coronary artery disease	4.46e-05	0.000187	CcSEcCtD
Leflunomide—Fatigue—Ramipril—coronary artery disease	4.45e-05	0.000187	CcSEcCtD
Leflunomide—Dyspepsia—Timolol—coronary artery disease	4.44e-05	0.000186	CcSEcCtD
Leflunomide—Hypersensitivity—Losartan—coronary artery disease	4.44e-05	0.000186	CcSEcCtD
Leflunomide—Nausea—Valsartan—coronary artery disease	4.42e-05	0.000186	CcSEcCtD
Leflunomide—Pruritus—Furosemide—coronary artery disease	4.42e-05	0.000185	CcSEcCtD
Leflunomide—Constipation—Ramipril—coronary artery disease	4.42e-05	0.000185	CcSEcCtD
Leflunomide—Nausea—Olmesartan—coronary artery disease	4.4e-05	0.000185	CcSEcCtD
Leflunomide—Vomiting—Trandolapril—coronary artery disease	4.4e-05	0.000185	CcSEcCtD
Leflunomide—Diarrhoea—Perindopril—coronary artery disease	4.39e-05	0.000184	CcSEcCtD
Leflunomide—Decreased appetite—Timolol—coronary artery disease	4.39e-05	0.000184	CcSEcCtD
Leflunomide—Vomiting—Enalapril—coronary artery disease	4.38e-05	0.000184	CcSEcCtD
Leflunomide—Hypotension—Lisinopril—coronary artery disease	4.38e-05	0.000184	CcSEcCtD
Leflunomide—Dizziness—Captopril—coronary artery disease	4.37e-05	0.000183	CcSEcCtD
Leflunomide—Rash—Trandolapril—coronary artery disease	4.37e-05	0.000183	CcSEcCtD
Leflunomide—Dermatitis—Trandolapril—coronary artery disease	4.36e-05	0.000183	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Timolol—coronary artery disease	4.36e-05	0.000183	CcSEcCtD
Leflunomide—Fatigue—Timolol—coronary artery disease	4.35e-05	0.000183	CcSEcCtD
Leflunomide—Rash—Enalapril—coronary artery disease	4.35e-05	0.000182	CcSEcCtD
Leflunomide—Dermatitis—Enalapril—coronary artery disease	4.34e-05	0.000182	CcSEcCtD
Leflunomide—Headache—Trandolapril—coronary artery disease	4.34e-05	0.000182	CcSEcCtD
Leflunomide—Vomiting—Telmisartan—coronary artery disease	4.32e-05	0.000181	CcSEcCtD
Leflunomide—Asthenia—Losartan—coronary artery disease	4.32e-05	0.000181	CcSEcCtD
Leflunomide—Headache—Enalapril—coronary artery disease	4.32e-05	0.000181	CcSEcCtD
Leflunomide—Pain—Timolol—coronary artery disease	4.32e-05	0.000181	CcSEcCtD
Leflunomide—Nausea—Niacin—coronary artery disease	4.3e-05	0.00018	CcSEcCtD
Leflunomide—Rash—Telmisartan—coronary artery disease	4.29e-05	0.00018	CcSEcCtD
Leflunomide—Dermatitis—Telmisartan—coronary artery disease	4.28e-05	0.00018	CcSEcCtD
Leflunomide—Diarrhoea—Furosemide—coronary artery disease	4.27e-05	0.000179	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Lisinopril—coronary artery disease	4.27e-05	0.000179	CcSEcCtD
Leflunomide—Pruritus—Losartan—coronary artery disease	4.26e-05	0.000179	CcSEcCtD
Leflunomide—Headache—Telmisartan—coronary artery disease	4.26e-05	0.000179	CcSEcCtD
Leflunomide—Feeling abnormal—Ramipril—coronary artery disease	4.26e-05	0.000179	CcSEcCtD
Leflunomide—Dizziness—Perindopril—coronary artery disease	4.25e-05	0.000178	CcSEcCtD
Leflunomide—Insomnia—Lisinopril—coronary artery disease	4.24e-05	0.000178	CcSEcCtD
Leflunomide—Nausea—Pravastatin—coronary artery disease	4.23e-05	0.000178	CcSEcCtD
Leflunomide—Gastrointestinal pain—Ramipril—coronary artery disease	4.22e-05	0.000177	CcSEcCtD
Leflunomide—Paraesthesia—Lisinopril—coronary artery disease	4.21e-05	0.000176	CcSEcCtD
Leflunomide—Vomiting—Captopril—coronary artery disease	4.2e-05	0.000176	CcSEcCtD
Leflunomide—Dyspnoea—Lisinopril—coronary artery disease	4.18e-05	0.000175	CcSEcCtD
Leflunomide—Rash—Captopril—coronary artery disease	4.17e-05	0.000175	CcSEcCtD
Leflunomide—Dermatitis—Captopril—coronary artery disease	4.17e-05	0.000175	CcSEcCtD
Leflunomide—Feeling abnormal—Timolol—coronary artery disease	4.16e-05	0.000175	CcSEcCtD
Leflunomide—Headache—Captopril—coronary artery disease	4.14e-05	0.000174	CcSEcCtD
Leflunomide—Gastrointestinal pain—Timolol—coronary artery disease	4.13e-05	0.000173	CcSEcCtD
Leflunomide—Dizziness—Furosemide—coronary artery disease	4.13e-05	0.000173	CcSEcCtD
Leflunomide—Dyspepsia—Lisinopril—coronary artery disease	4.12e-05	0.000173	CcSEcCtD
Leflunomide—Diarrhoea—Losartan—coronary artery disease	4.12e-05	0.000173	CcSEcCtD
Leflunomide—Nausea—Trandolapril—coronary artery disease	4.11e-05	0.000173	CcSEcCtD
Leflunomide—Urticaria—Ramipril—coronary artery disease	4.1e-05	0.000172	CcSEcCtD
Leflunomide—Nausea—Enalapril—coronary artery disease	4.1e-05	0.000172	CcSEcCtD
Leflunomide—Vomiting—Perindopril—coronary artery disease	4.08e-05	0.000171	CcSEcCtD
Leflunomide—Body temperature increased—Ramipril—coronary artery disease	4.08e-05	0.000171	CcSEcCtD
Leflunomide—Abdominal pain—Ramipril—coronary artery disease	4.08e-05	0.000171	CcSEcCtD
Leflunomide—Decreased appetite—Lisinopril—coronary artery disease	4.07e-05	0.000171	CcSEcCtD
Leflunomide—Rash—Perindopril—coronary artery disease	4.05e-05	0.00017	CcSEcCtD
Leflunomide—Dermatitis—Perindopril—coronary artery disease	4.04e-05	0.00017	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Lisinopril—coronary artery disease	4.04e-05	0.00017	CcSEcCtD
Leflunomide—Nausea—Telmisartan—coronary artery disease	4.04e-05	0.000169	CcSEcCtD
Leflunomide—Fatigue—Lisinopril—coronary artery disease	4.04e-05	0.000169	CcSEcCtD
Leflunomide—Headache—Perindopril—coronary artery disease	4.02e-05	0.000169	CcSEcCtD
Leflunomide—Urticaria—Timolol—coronary artery disease	4.01e-05	0.000168	CcSEcCtD
Leflunomide—Pain—Lisinopril—coronary artery disease	4.01e-05	0.000168	CcSEcCtD
Leflunomide—Constipation—Lisinopril—coronary artery disease	4.01e-05	0.000168	CcSEcCtD
Leflunomide—Abdominal pain—Timolol—coronary artery disease	3.99e-05	0.000167	CcSEcCtD
Leflunomide—Body temperature increased—Timolol—coronary artery disease	3.99e-05	0.000167	CcSEcCtD
Leflunomide—Dizziness—Losartan—coronary artery disease	3.98e-05	0.000167	CcSEcCtD
Leflunomide—Vomiting—Furosemide—coronary artery disease	3.97e-05	0.000166	CcSEcCtD
Leflunomide—Rash—Furosemide—coronary artery disease	3.94e-05	0.000165	CcSEcCtD
Leflunomide—Dermatitis—Furosemide—coronary artery disease	3.93e-05	0.000165	CcSEcCtD
Leflunomide—Nausea—Captopril—coronary artery disease	3.93e-05	0.000165	CcSEcCtD
Leflunomide—Headache—Furosemide—coronary artery disease	3.91e-05	0.000164	CcSEcCtD
Leflunomide—Feeling abnormal—Lisinopril—coronary artery disease	3.86e-05	0.000162	CcSEcCtD
Leflunomide—Gastrointestinal pain—Lisinopril—coronary artery disease	3.83e-05	0.000161	CcSEcCtD
Leflunomide—Vomiting—Losartan—coronary artery disease	3.83e-05	0.000161	CcSEcCtD
Leflunomide—Nausea—Perindopril—coronary artery disease	3.81e-05	0.00016	CcSEcCtD
Leflunomide—Hypersensitivity—Ramipril—coronary artery disease	3.8e-05	0.00016	CcSEcCtD
Leflunomide—Rash—Losartan—coronary artery disease	3.8e-05	0.000159	CcSEcCtD
Leflunomide—Dermatitis—Losartan—coronary artery disease	3.79e-05	0.000159	CcSEcCtD
Leflunomide—Headache—Losartan—coronary artery disease	3.77e-05	0.000158	CcSEcCtD
Leflunomide—Urticaria—Lisinopril—coronary artery disease	3.72e-05	0.000156	CcSEcCtD
Leflunomide—Hypersensitivity—Timolol—coronary artery disease	3.72e-05	0.000156	CcSEcCtD
Leflunomide—Nausea—Furosemide—coronary artery disease	3.71e-05	0.000156	CcSEcCtD
Leflunomide—Asthenia—Ramipril—coronary artery disease	3.71e-05	0.000155	CcSEcCtD
Leflunomide—Abdominal pain—Lisinopril—coronary artery disease	3.7e-05	0.000155	CcSEcCtD
Leflunomide—Body temperature increased—Lisinopril—coronary artery disease	3.7e-05	0.000155	CcSEcCtD
Leflunomide—Pruritus—Ramipril—coronary artery disease	3.65e-05	0.000153	CcSEcCtD
Leflunomide—Asthenia—Timolol—coronary artery disease	3.62e-05	0.000152	CcSEcCtD
Leflunomide—Nausea—Losartan—coronary artery disease	3.58e-05	0.00015	CcSEcCtD
Leflunomide—Pruritus—Timolol—coronary artery disease	3.57e-05	0.00015	CcSEcCtD
Leflunomide—Diarrhoea—Ramipril—coronary artery disease	3.53e-05	0.000148	CcSEcCtD
Leflunomide—Diarrhoea—Timolol—coronary artery disease	3.45e-05	0.000145	CcSEcCtD
Leflunomide—Hypersensitivity—Lisinopril—coronary artery disease	3.45e-05	0.000145	CcSEcCtD
Leflunomide—Dizziness—Ramipril—coronary artery disease	3.41e-05	0.000143	CcSEcCtD
Leflunomide—Asthenia—Lisinopril—coronary artery disease	3.36e-05	0.000141	CcSEcCtD
Leflunomide—Dizziness—Timolol—coronary artery disease	3.34e-05	0.00014	CcSEcCtD
Leflunomide—Pruritus—Lisinopril—coronary artery disease	3.31e-05	0.000139	CcSEcCtD
Leflunomide—Vomiting—Ramipril—coronary artery disease	3.28e-05	0.000138	CcSEcCtD
Leflunomide—Rash—Ramipril—coronary artery disease	3.26e-05	0.000137	CcSEcCtD
Leflunomide—Dermatitis—Ramipril—coronary artery disease	3.25e-05	0.000136	CcSEcCtD
Leflunomide—Headache—Ramipril—coronary artery disease	3.24e-05	0.000136	CcSEcCtD
Leflunomide—Vomiting—Timolol—coronary artery disease	3.21e-05	0.000135	CcSEcCtD
Leflunomide—Diarrhoea—Lisinopril—coronary artery disease	3.2e-05	0.000134	CcSEcCtD
Leflunomide—Rash—Timolol—coronary artery disease	3.18e-05	0.000134	CcSEcCtD
Leflunomide—Dermatitis—Timolol—coronary artery disease	3.18e-05	0.000133	CcSEcCtD
Leflunomide—Headache—Timolol—coronary artery disease	3.16e-05	0.000133	CcSEcCtD
Leflunomide—Dizziness—Lisinopril—coronary artery disease	3.1e-05	0.00013	CcSEcCtD
Leflunomide—Nausea—Ramipril—coronary artery disease	3.07e-05	0.000129	CcSEcCtD
Leflunomide—Nausea—Timolol—coronary artery disease	3e-05	0.000126	CcSEcCtD
Leflunomide—Vomiting—Lisinopril—coronary artery disease	2.98e-05	0.000125	CcSEcCtD
Leflunomide—Rash—Lisinopril—coronary artery disease	2.95e-05	0.000124	CcSEcCtD
Leflunomide—Dermatitis—Lisinopril—coronary artery disease	2.95e-05	0.000124	CcSEcCtD
Leflunomide—Headache—Lisinopril—coronary artery disease	2.93e-05	0.000123	CcSEcCtD
Leflunomide—Nausea—Lisinopril—coronary artery disease	2.78e-05	0.000117	CcSEcCtD
Leflunomide—CYP1A2—Metabolism—MDH2—coronary artery disease	9.89e-06	8.13e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—KDR—coronary artery disease	9.83e-06	8.08e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PSMB5—coronary artery disease	9.83e-06	8.07e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PSMA6—coronary artery disease	9.83e-06	8.07e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MAPK14—coronary artery disease	9.76e-06	8.02e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	9.62e-06	7.9e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CTGF—coronary artery disease	9.6e-06	7.89e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SULT1E1—coronary artery disease	9.59e-06	7.88e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ESR1—coronary artery disease	9.58e-06	7.87e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PGM1—coronary artery disease	9.52e-06	7.82e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GOT2—coronary artery disease	9.51e-06	7.82e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HMGCR—coronary artery disease	9.51e-06	7.82e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—F2—coronary artery disease	9.46e-06	7.77e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—FN1—coronary artery disease	9.46e-06	7.77e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6ST—coronary artery disease	9.42e-06	7.74e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NFKBIA—coronary artery disease	9.35e-06	7.68e-05	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—ALB—coronary artery disease	9.33e-06	7.66e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	9.31e-06	7.65e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	9.3e-06	7.64e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	9.22e-06	7.58e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CKB—coronary artery disease	9.19e-06	7.55e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PYGB—coronary artery disease	9.19e-06	7.55e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—AKR1B1—coronary artery disease	9.15e-06	7.52e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HK2—coronary artery disease	9.15e-06	7.52e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—KIT—coronary artery disease	9.05e-06	7.44e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SLC27A1—coronary artery disease	8.77e-06	7.21e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PLCB1—coronary artery disease	8.75e-06	7.19e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GSK3B—coronary artery disease	8.69e-06	7.14e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—COX5B—coronary artery disease	8.64e-06	7.1e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GSTM2—coronary artery disease	8.64e-06	7.1e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—DLAT—coronary artery disease	8.64e-06	7.1e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PLIN1—coronary artery disease	8.64e-06	7.1e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PFKFB3—coronary artery disease	8.64e-06	7.1e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—POMC—coronary artery disease	8.62e-06	7.08e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CREB1—coronary artery disease	8.62e-06	7.08e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CPT1B—coronary artery disease	8.6e-06	7.07e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—LCAT—coronary artery disease	8.6e-06	7.07e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ABCA1—coronary artery disease	8.48e-06	6.97e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOA4—coronary artery disease	8.44e-06	6.94e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCL2—coronary artery disease	8.43e-06	6.93e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6R—coronary artery disease	8.41e-06	6.91e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IGF1—coronary artery disease	8.29e-06	6.81e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	8.29e-06	6.81e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	8.22e-06	6.75e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GOT1—coronary artery disease	8.21e-06	6.75e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GGT1—coronary artery disease	8.21e-06	6.75e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SULT1E1—coronary artery disease	8.19e-06	6.73e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PDHA1—coronary artery disease	8.15e-06	6.7e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GCLM—coronary artery disease	8.15e-06	6.7e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	7.96e-06	6.54e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	7.9e-06	6.49e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—TXNRD1—coronary artery disease	7.9e-06	6.49e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP11B2—coronary artery disease	7.9e-06	6.49e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SERPINE1—coronary artery disease	7.87e-06	6.47e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HK2—coronary artery disease	7.82e-06	6.42e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—AKR1B1—coronary artery disease	7.82e-06	6.42e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SLC22A3—coronary artery disease	7.78e-06	6.39e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ARNTL—coronary artery disease	7.67e-06	6.3e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HADH—coronary artery disease	7.67e-06	6.3e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—FGF2—coronary artery disease	7.62e-06	6.26e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	7.55e-06	6.2e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—MAPK1—coronary artery disease	7.54e-06	6.19e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NOS3—coronary artery disease	7.52e-06	6.18e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SLC27A1—coronary artery disease	7.49e-06	6.16e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GSTP1—coronary artery disease	7.38e-06	6.06e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	7.36e-06	6.05e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—LCAT—coronary artery disease	7.35e-06	6.04e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CPT1B—coronary artery disease	7.35e-06	6.04e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PPARGC1A—coronary artery disease	7.31e-06	6.01e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—JAK2—coronary artery disease	7.3e-06	6e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HMOX1—coronary artery disease	7.27e-06	5.98e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GPX2—coronary artery disease	7.27e-06	5.97e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOA2—coronary artery disease	7.27e-06	5.97e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PLA2G2A—coronary artery disease	7.27e-06	5.97e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOA4—coronary artery disease	7.21e-06	5.93e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CAT—coronary artery disease	7.18e-06	5.9e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GPX4—coronary artery disease	7.18e-06	5.9e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ABCG5—coronary artery disease	7.18e-06	5.9e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HK1—coronary artery disease	7.18e-06	5.9e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SULT1A1—coronary artery disease	7.18e-06	5.9e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	7.17e-06	5.89e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HADHA—coronary artery disease	7.09e-06	5.83e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	7.08e-06	5.82e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GSTA1—coronary artery disease	7.01e-06	5.76e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—APOB—coronary artery disease	6.97e-06	5.73e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PDHA1—coronary artery disease	6.97e-06	5.72e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GCLM—coronary artery disease	6.97e-06	5.72e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—LPA—coronary artery disease	6.93e-06	5.7e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GSTM1—coronary artery disease	6.78e-06	5.57e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	6.75e-06	5.55e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—TXNRD1—coronary artery disease	6.75e-06	5.54e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP11B2—coronary artery disease	6.75e-06	5.54e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PLCB3—coronary artery disease	6.71e-06	5.52e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CXCL8—coronary artery disease	6.67e-06	5.48e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—LPL—coronary artery disease	6.65e-06	5.47e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SLC22A3—coronary artery disease	6.65e-06	5.46e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOA5—coronary artery disease	6.65e-06	5.46e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ARNTL—coronary artery disease	6.55e-06	5.38e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HADH—coronary artery disease	6.55e-06	5.38e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PIK3CA—coronary artery disease	6.54e-06	5.37e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—P4HB—coronary artery disease	6.52e-06	5.36e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GPX1—coronary artery disease	6.49e-06	5.33e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	6.46e-06	5.3e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	6.45e-06	5.3e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	6.4e-06	5.26e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CASP3—coronary artery disease	6.38e-06	5.24e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	6.33e-06	5.2e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CD36—coronary artery disease	6.32e-06	5.19e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	6.29e-06	5.17e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	6.25e-06	5.14e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PPP2CA—coronary artery disease	6.24e-06	5.13e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCND1—coronary artery disease	6.21e-06	5.1e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOA2—coronary artery disease	6.21e-06	5.1e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PLA2G2A—coronary artery disease	6.21e-06	5.1e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GPX2—coronary artery disease	6.21e-06	5.1e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HK1—coronary artery disease	6.13e-06	5.04e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ABCG5—coronary artery disease	6.13e-06	5.04e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GPX4—coronary artery disease	6.13e-06	5.04e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SULT1A1—coronary artery disease	6.13e-06	5.04e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	6.13e-06	5.03e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HADHA—coronary artery disease	6.06e-06	4.98e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—VCAN—coronary artery disease	6.03e-06	4.96e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MMP9—coronary artery disease	6.03e-06	4.95e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GSTA1—coronary artery disease	5.99e-06	4.92e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—MTHFR—coronary artery disease	5.99e-06	4.92e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALDOA—coronary artery disease	5.98e-06	4.92e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—LPA—coronary artery disease	5.92e-06	4.87e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—DCN—coronary artery disease	5.81e-06	4.77e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6—coronary artery disease	5.79e-06	4.76e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PLCB3—coronary artery disease	5.74e-06	4.71e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—AGT—coronary artery disease	5.69e-06	4.68e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOA5—coronary artery disease	5.68e-06	4.67e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALDH2—coronary artery disease	5.65e-06	4.64e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—APOE—coronary artery disease	5.58e-06	4.58e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—P4HB—coronary artery disease	5.57e-06	4.58e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	5.52e-06	4.53e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—APOA1—coronary artery disease	5.51e-06	4.53e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	5.51e-06	4.53e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HBA1—coronary artery disease	5.51e-06	4.53e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—LIPC—coronary artery disease	5.51e-06	4.53e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP2C19—coronary artery disease	5.51e-06	4.53e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	5.51e-06	4.53e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOC3—coronary artery disease	5.47e-06	4.5e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	5.47e-06	4.49e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—LDLR—coronary artery disease	5.44e-06	4.47e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	5.43e-06	4.46e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—VEGFA—coronary artery disease	5.41e-06	4.45e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	5.41e-06	4.44e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GSTT1—coronary artery disease	5.38e-06	4.42e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SLC9A1—coronary artery disease	5.38e-06	4.42e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	5.34e-06	4.39e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—AKT1—coronary artery disease	5.34e-06	4.39e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CETP—coronary artery disease	5.31e-06	4.37e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GCLC—coronary artery disease	5.31e-06	4.37e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SDC1—coronary artery disease	5.25e-06	4.32e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—VCAN—coronary artery disease	5.15e-06	4.23e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALDOA—coronary artery disease	5.11e-06	4.2e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TGFB1—coronary artery disease	4.97e-06	4.08e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—DCN—coronary artery disease	4.96e-06	4.08e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PSMB5—coronary artery disease	4.96e-06	4.08e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PSMA6—coronary artery disease	4.96e-06	4.08e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	4.95e-06	4.07e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MAPK1—coronary artery disease	4.87e-06	4e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PPARG—coronary artery disease	4.86e-06	3.99e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CTGF—coronary artery disease	4.85e-06	3.98e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALDH2—coronary artery disease	4.83e-06	3.97e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HMGCR—coronary artery disease	4.8e-06	3.95e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GOT2—coronary artery disease	4.8e-06	3.95e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—POMC—coronary artery disease	4.79e-06	3.94e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	4.71e-06	3.87e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HBA1—coronary artery disease	4.71e-06	3.87e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—LIPC—coronary artery disease	4.71e-06	3.87e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	4.71e-06	3.87e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP2C19—coronary artery disease	4.71e-06	3.87e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOC3—coronary artery disease	4.68e-06	3.84e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—LDLR—coronary artery disease	4.65e-06	3.82e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	4.64e-06	3.82e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SLC9A1—coronary artery disease	4.59e-06	3.77e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GSTT1—coronary artery disease	4.59e-06	3.77e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GCLC—coronary artery disease	4.54e-06	3.73e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CETP—coronary artery disease	4.54e-06	3.73e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SDC1—coronary artery disease	4.49e-06	3.69e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PLCB1—coronary artery disease	4.42e-06	3.63e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALB—coronary artery disease	4.37e-06	3.59e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.33e-06	3.56e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ABCA1—coronary artery disease	4.28e-06	3.52e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PSMA6—coronary artery disease	4.24e-06	3.48e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PSMB5—coronary artery disease	4.24e-06	3.48e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	4.23e-06	3.48e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PIK3CA—coronary artery disease	4.23e-06	3.47e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NOS3—coronary artery disease	4.18e-06	3.43e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GGT1—coronary artery disease	4.15e-06	3.41e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GOT1—coronary artery disease	4.15e-06	3.41e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CTGF—coronary artery disease	4.14e-06	3.4e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HMGCR—coronary artery disease	4.11e-06	3.37e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GOT2—coronary artery disease	4.11e-06	3.37e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PTGS2—coronary artery disease	3.82e-06	3.14e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PLCB1—coronary artery disease	3.78e-06	3.1e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6—coronary artery disease	3.74e-06	3.08e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GSTP1—coronary artery disease	3.73e-06	3.06e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.7e-06	3.04e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	3.69e-06	3.03e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HMOX1—coronary artery disease	3.67e-06	3.02e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ABCA1—coronary artery disease	3.66e-06	3.01e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CAT—coronary artery disease	3.63e-06	2.98e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GGT1—coronary artery disease	3.54e-06	2.91e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GOT1—coronary artery disease	3.54e-06	2.91e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOB—coronary artery disease	3.52e-06	2.89e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—AKT1—coronary artery disease	3.45e-06	2.84e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GSTM1—coronary artery disease	3.42e-06	2.81e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—LPL—coronary artery disease	3.36e-06	2.76e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GPX1—coronary artery disease	3.28e-06	2.69e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CD36—coronary artery disease	3.19e-06	2.62e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GSTP1—coronary artery disease	3.18e-06	2.62e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	3.15e-06	2.59e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPP2CA—coronary artery disease	3.15e-06	2.59e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HMOX1—coronary artery disease	3.14e-06	2.58e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CAT—coronary artery disease	3.1e-06	2.55e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—MTHFR—coronary artery disease	3.03e-06	2.49e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOB—coronary artery disease	3.01e-06	2.47e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GSTM1—coronary artery disease	2.93e-06	2.4e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—AGT—coronary artery disease	2.87e-06	2.36e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—LPL—coronary artery disease	2.87e-06	2.36e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOE—coronary artery disease	2.82e-06	2.31e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GPX1—coronary artery disease	2.8e-06	2.3e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOA1—coronary artery disease	2.78e-06	2.29e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CD36—coronary artery disease	2.73e-06	2.24e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPP2CA—coronary artery disease	2.69e-06	2.21e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.67e-06	2.19e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—MTHFR—coronary artery disease	2.59e-06	2.12e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—AGT—coronary artery disease	2.46e-06	2.02e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPARG—coronary artery disease	2.45e-06	2.02e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—POMC—coronary artery disease	2.42e-06	1.99e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOE—coronary artery disease	2.41e-06	1.98e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOA1—coronary artery disease	2.38e-06	1.96e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PIK3CA—coronary artery disease	2.35e-06	1.93e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.28e-06	1.87e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALB—coronary artery disease	2.21e-06	1.81e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NOS3—coronary artery disease	2.11e-06	1.73e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPARG—coronary artery disease	2.1e-06	1.72e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—POMC—coronary artery disease	2.07e-06	1.7e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.93e-06	1.59e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—AKT1—coronary artery disease	1.92e-06	1.58e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALB—coronary artery disease	1.89e-06	1.55e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NOS3—coronary artery disease	1.8e-06	1.48e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.65e-06	1.36e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1.19e-06	9.76e-06	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PIK3CA—coronary artery disease	1.01e-06	8.34e-06	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—AKT1—coronary artery disease	9.7e-07	7.97e-06	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—AKT1—coronary artery disease	8.29e-07	6.81e-06	CbGpPWpGaD
